Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT02090413 · COMPLETED
Trial details
- NCT number
- NCT02090413
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-02-01
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.